Andrew Bellinger
21Patents
9h-index
28Co-inventors
67Inventor score
Filing activity: Jun 11, 2015 → Feb 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10182985B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 25 | Active |
| US10413507B2 | Enteric elastomers | Emerging Cross-Sectional Technologies | 14 | Active |
| US10532027B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 12 | Active |
| US10517820B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 11 | Active |
| US10610482B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 11 | Active |
| US10716751B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 10 | Active |
| US10517819B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 10 | Active |
| US10716752B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 10 | Active |
| US10596110B2 | Residence structures and related methods | Human Necessities | 9 | Active |
| US11077056B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 6 | Active |
| US11389399B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 4 | Active |
| US11357723B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 4 | Active |
| US10849853B2 | Self-assembled residence devices and related methods | Emerging Cross-Sectional Technologies | 4 | Active |
| US11246829B2 | Residence structures and related methods | Emerging Cross-Sectional Technologies | 4 | Active |
| US11576866B2 | Gastric residence systems for sustained delivery of adamantane-class drugs | Human Necessities | 2 | Active |
| US11083690B2 | Enteric elastomers | Emerging Cross-Sectional Technologies | 1 | Active |
| US11576859B2 | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof | Human Necessities | 1 | Active |
| US12109305B2 | Materials architecture for gastric residence systems | Human Necessities | 0 | Active |
| US11992552B2 | Geometric configurations for gastric residence systems | Chemistry; Metallurgy | 0 | Active |
| US12023406B2 | Gastric residence systems with release rate-modulating films | Human Necessities | 0 | Active |
| US12383495B2 | Resident articles for gram-level dosing | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.